NASDAQ · CHEMICALS & ALLIED PRODUCTS · MID CAP
Ascent Industries Co. ACNT
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$74.9M
▼ 7.2% vs FY2024
Dividend streak
1 yrs
Raised every year since 2025
EPS · FY25
$0.09
Dividend / sh · FY25
$0.00
Payout · FY25
—
ROE · FY25
1.0%
Net margin · FY25
1.2%
Dividend coverage
1.0×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 74.9M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
1 cents of every revenue dollar became profit this year.
Per share
USD 0.09
Diluted EPS, FY2025
EPS
Dividend
Earnings covered only a fraction of the dividend — the rest came from cash or borrowing.
Profitability
1.0%
Return on equity, FY2025
ROE
Operating margin-9.4%
Net margin1.2%
Return on assets0.7%
Each USD of equity produced 1 cents of profit this year.
Returned to shareholders
USD 8.7M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 8.7M
Share of profit1006.0%
Consecutive raises1 years
USD 8.7M in buybacks — 1006% of the year's profit, so the payout drew on cash built up earlier.
Growth
−21.8% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−34.1%
−21.8%
−8.2%
−4.6%
Net income
−66.0%
−9.7%
EPS, diluted
−65.1%
−12.3%
Returned to shareholders
+95.5%
+68.9%
+9.8%
+7.0%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 111.9M
total assets, end of FY2025
Total assetsUSD 111.9M
EquityUSD 87.0M
CashUSD 57.6M
Current ratio6.72×
Equity funds 78% of total assets.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.1
0.1
0.2
0.3
0.3
0.3
0.3
0.3
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.1
Operating income $B
−0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
EBITDA $B
−0.0
−0.0
−0.0
0.0
0.0
−0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
Income tax $B
0.0
0.0
−0.0
−0.0
0.0
−0.0
−0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
EPS, diluted $
0.09
−1.35
−2.63
2.12
2.14
−2.98
−0.34
·
·
·
·
·
0.25
0.66
0.91
0.64
0.03
Dividend / sh $
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.25
0.13
0.30
0.30
0.30
0.26
0.25
0.25
0.50
0.10
Payout %
·
·
·
·
·
·
−0
17
86
−0
−23
48
128
38
27
78
·
ROE %
1.0
−13.5
−22.0
18.0
21.1
−29.2
−2.9
13.6
1.5
−7.7
−11.3
5.1
2.0
6.0
8.8
6.4
0.3
Shares out B
0.01
0.01
0.01
0.01
0.01
·
·
·
·
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
50 of 50
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed